These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22396326)

  • 1. Re: usefulness of dynamic urethral resistance relation (DURR) measurement for differential diagnosis between static and dynamic urinary obstruction in male spinal cord injury patients. Neurourol urodyn 2012;31:549-55.
    Rosier PF
    Neurourol Urodyn; 2012 Apr; 31(4):556. PubMed ID: 22396326
    [No Abstract]   [Full Text] [Related]  

  • 2. Usefulness of Dynamic Urethral Resistance Relation (DURR) measurement for differential diagnosis between static and dynamic urinary obstruction in male spinal cord injury patients.
    Vírseda M; Salinas J; López A; Esteban M
    Neurourol Urodyn; 2012 Apr; 31(4):549-55. PubMed ID: 22396315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
    Kaplan SA
    J Urol; 2005 Sep; 174(3):1011. PubMed ID: 16094031
    [No Abstract]   [Full Text] [Related]  

  • 4. Differentiation between neurogenic and prostatic obstruction using the intraprostatic spiral. A case report.
    Ovesen H; Poulsen AL; Nordling J
    Scand J Urol Nephrol; 1990; 24(3):179-80. PubMed ID: 1700470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can neurologic examination predict type of detrusor sphincter-dyssynergia in patients with spinal cord injury?
    Schurch B; Schmid DM; Karsenty G; Reitz A
    Urology; 2005 Feb; 65(2):243-6. PubMed ID: 15708030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dysuria. Typical symptoms for proper diagnosis].
    Altwein JE
    MMW Fortschr Med; 2001 Nov; 143 Suppl():121-30; quiz 131-2. PubMed ID: 11797592
    [No Abstract]   [Full Text] [Related]  

  • 7. Real-time gray-scale transrectal linear array ultrasonography in urodynamic evaluation.
    Perkash I; Friedland GW
    Semin Urol; 1985 Feb; 3(1):49-59. PubMed ID: 2408307
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of uroflowmetry as a method of evaluating obstruction of the lower urinary tract].
    Minkov N; Kunchev S; Deliĭski P; Gotsev G
    Khirurgiia (Sofiia); 1983; 36(6):551-6. PubMed ID: 6199550
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute urinary retention].
    Kokott P
    MMW Fortschr Med; 2008 Dec; 150(49-50):41. PubMed ID: 19133369
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation between lower urinary tract symptoms and urethral function in benign prostatic hyperplasia.
    Kaplan SA
    J Urol; 2005 Sep; 174(3):1010-1. PubMed ID: 16094029
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epidemiology and diagnosis of benign prostata hyperplasia].
    Schlenker B; Seitz M; Reich O; Stief CG; Gratzke C
    MMW Fortschr Med; 2009 Oct; 151(41):31-2. PubMed ID: 19891181
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediction of prostatic obstruction with a combination of isometric detrusor contraction pressure and maximum urinary flow rate.
    Comiter CV; Sullivan MP; Schacterle RS; Yalla SV
    Urology; 1996 Nov; 48(5):723-9; discussion 729-30. PubMed ID: 8911516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [BPH, fight bladder and bladder lithiasis].
    Galiano Baena JF; Caballero Romeu JP; Herrero Polo E
    Actas Urol Esp; 2009 Apr; 33(4):453. PubMed ID: 19579902
    [No Abstract]   [Full Text] [Related]  

  • 14. Can noninvasive evaluation of benign prostatic obstruction be optimized?
    Løvvik A; Yaqub S; Oustad H; Sand TE; Nitti VW
    Curr Opin Urol; 2012 Jan; 22(1):1-6. PubMed ID: 22080874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    van Venrooij GE; Eckhardt MD; Boon TA
    Urology; 2004 Mar; 63(3):476-80. PubMed ID: 15028441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of DURR (dynamic urethral resistance factor) in the study of prostatism].
    Salinas Casado J; Aristizabal Agudelo JM; Virseda Chamorro M; Esteban Fuertes M; Resel Estévez L
    Arch Esp Urol; 1996 May; 49(4):405-12. PubMed ID: 8754196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic scale of infravesical obstruction in patients d with benign prostatic hyperplasia].
    Aboian IA; Golovko SIu; Khitar'ian AG; Levin EG; Pavlov SV
    Urol Nefrol (Mosk); 1998; (6):32-7. PubMed ID: 10051826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmaco-profilometry using alpha-1a adrenergic blockers in the diagnosis of dynamic infravesical obstruction in the vesicourethral zone segment].
    Mazo EB; Chepurov AK; Krivoborodov GG; Tarasova EV; Malenko VP
    Urol Nefrol (Mosk); 1998; (6):21-4. PubMed ID: 10051822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstructive voiding symptoms secondary to prostate disease. American College of Radiology. ACR Appropriateness Criteria.
    Bluth EI; Amis ES; Bigongiari LR; Bush WH; Choyke PL; Fritzsche P; Holder L; Newhouse JH; Sandler CM; Segal AJ; Resnick MI; Rutsky EA
    Radiology; 2000 Jun; 215 Suppl():693-6. PubMed ID: 11037486
    [No Abstract]   [Full Text] [Related]  

  • 20. Routine bladder biopsies in men with bladder outlet obstruction?
    Horn T; Kortmann BB; Holm NR; Smedts F; Nordling J; Kiemeney LA; de la Rosette JJ
    Urology; 2004 Mar; 63(3):451-6. PubMed ID: 15028436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.